Literature DB >> 7357507

Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.

S Spiegelman, R Nayak, R Sawyer, R Stolfi, D Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7357507     DOI： 10.1002/1097-0142(19800315)45:5+<1129::aid-cncr2820451317>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

Review 1.  How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors:  P Ragnhammar; H Blomgren
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

Review 2.  DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets.

Authors:  Long Shan Li; Julio C Morales; Martina Veigl; David Sedwick; Sheldon Greer; Mark Meyers; Mark Wagner; Richard Fishel; David A Boothman
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

3.  Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.

Authors:  G Santelli; F Valeriote
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Modulation of 5-FU metabolism in human MCF-7 breast carcinoma cells.

Authors:  P P Major; E M Egan; L Sargent; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.

Authors:  R Tausch-Treml; F Baumgart; D Ziessow; P Köpf-Maier
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

6.  A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma.

Authors:  A Sternberg; N J Petrelli; J Au; Y Rustum; A Mittelman; P Creaven
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Pyrimidine nucleoside phosphorylase activity in tumour and matched normal gastrointestinal mucosa.

Authors:  B Higley; J Oakes; J De Mello; G R Giles
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

8.  Uridine rescue from the lethal toxicity of 5-fluorouracil in mice.

Authors:  P Klubes; I Cerna; M A Meldon
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.

Authors:  C Benz; M Choti; L Newcomer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 10.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.